Found 5 matching trials
An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)
PHASE2The purpose of this Phase IIa study is to evaluate the safety and tolerabil...
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
PHASE2The purpose of this Phase IIa study is to evaluate the safety, tolerability...
Location
University of Alabama at Birmingham
ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers
PHASE1The purpose of this study is to evaluate the safety of ALLN-346 in healthy ...
Location
Medpace Clinical Pharmacology
Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)
PHASE1The purpose of this Phase I study is to evaluate the safety and tolerabilit...
Location
Medpace Clinical Pharmacology
Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets
PHASE1The purpose of the study is to understand the gastrointestinal transit time...
Location
BDD Pharma Ltd Bio-Imaging Centre Within Glasgow Royal Infirmary